Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3033

Actual shortage: 243 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CIPROFLOX 0.3% SOLUTION Resolved 2017-03-10 2019-06-12 110
APO-OFLOXACIN 0.3% SOLUTION Resolved 2017-03-10 2019-01-08 405
APO-TOBRAMYCIN 0.3% SOLUTION Actual shortage 2017-08-14 2017-10-05 19123
APO-GATIFLOXACIN 0.3% SOLUTION Resolved 2023-09-28 2023-11-24 205486
APO-GATIFLOXACIN 0.3% SOLUTION Resolved 2024-03-27 2024-04-12 223555
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Resolved 2017-03-10 2018-02-26 402
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-05-10 2017-05-13 9946
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-17 2017-10-24 15995
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-26 2017-11-13 17331
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-28 2018-01-22 31039
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-15 2019-02-21 72363
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-24 2019-06-21 82337
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-15 2019-06-24 84159
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-06-05 2019-06-21 85619
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-09-02 2021-02-23 123581
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-09-17 2021-02-23 124359
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-07 2021-02-23 125824
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-08-19 2022-10-14 167421
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-02-02 177600
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-06 2023-04-21 188973

Showing 101 to 120 of 3033

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40811
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40814
APO-ATORVASTATIN 40MG TABLET Discontinued 2018-09-07 2018-11-09 60282
APO-FUROSEMIDE 40MG TABLET Discontinued 2018-09-07 2018-09-15 60509
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-02-13 60769
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-08-08 60772
APO-TELMISARTAN 40MG TABLET Discontinued 2019-01-04 2019-01-04 71345
APO-VALGANCICLOVIR 450MG TABLET Discontinued 2018-09-08 2018-09-15 60843
APO-SALVENT TABLETS - 4MG 4MG TABLET Discontinued 2018-02-23 2018-07-17 40847
APO-CANDESARTAN 4MG TABLET Discontinued 2018-09-07 2018-09-15 60319
APO-OLANZAPINE 5.0MG TABLET Discontinued 2017-03-31 2018-02-05 4968
ACETAMINOPHEN HEADACHE ULTRA RELIEF 500MG 65MG TABLET Discontinued 2019-01-04 2019-01-04 71192
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-METFORMIN 500MG TABLET Discontinued 2018-02-23 2018-11-26 40790
APO-CEFPROZIL 500MG TABLET Discontinued 2018-04-04 2018-10-05 44945
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH 500MG TABLET Discontinued 2018-09-07 2018-09-08 60157
APO-AMOXI 500MG CAPSULE Discontinued 2018-09-07 2018-11-09 60174
APO-CIPROFLOX 500MG TABLET Discontinued 2018-09-07 2018-09-15 60382

Showing 261 to 280 of 356